Gastro-oesophageal reflux is a normal physiological event, whereas gastro-oesophageal reflux disease (GORD) occurs when this process causes symptoms severe enough to merit medical treatment or when there are associated complications. In infants and children it is particularly difficult to differentiate between the two conditions because of the wide variety of potential symptoms and the lack of a simple, reliable, and widely available diagnostic test. The true burden of the problem is therefore difficult to quantify, and it is accepted that clinical practice varies greatly.
Children affected by the disease include premature and term neonates, otherwise well infants and children, and those with known risk factors, such as repaired diaphragmatic hernia and other congenital anomalies or severe neurodisabilities. This last group of children may have complex comorbidities and the underlying pathophysiology may have important differences.
This article summarises the most recent guidance from the National Institute for Health and Care Excellence (NICE) on how to recognise, diagnose, and manage gastro-oesophageal reflux disease in infants, children, and young people. 
Recommendations
NICE recommendations are based on systematic reviews of best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the guideline development group's experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets.
Diagnosing and investigating gastro-oesophageal reflux disease
• Recognise regurgitation of feeds as a common and normal occurrence in infants and that it: -Is caused by gastro-oesophageal reflux-a normal physiological process in infancy (the box outlines the definitions of gastro-oesophageal reflux and GORD used in this guideline) -Does not usually need any investigation or treatment -Is managed by advising and reassuring parents and carers.
[Based on high, moderate, and low quality evidence from observational studies and on the experience and opinion of the Guideline Development Group (GDG) .]
• Be aware that in a small proportion of infants, gastro-oesophageal reflux may be associated with signs of distress or may lead to certain recognised complications that need clinical management. This is known as gastro-oesophageal reflux disease. [Based on the experience and opinion of the GDG.]
• Give advice about gastro-oesophageal reflux, and reassure parents and carers that in well infants effortless regurgitation of feeds: -Is common (affects at least 40% of infants)
-Usually begins before the infant is 8 weeks old -May be frequent (5% of those affected have six or more episodes a day)
The bottom line
• Frequent, effortless regurgitation of feeds is common during early infancy. Although worrying for parents, it usually resolves by the age of 1 year and usually does not need investigation or specific treatment. Effective management requires detailed, repeated, and confident reassurance
• For infants and children who present with regurgitation or vomiting, actively look out for "red flags" (such as projectile vomiting, bile stained vomiting, haematemesis, blood in stool, abdominal distension, or systemic features) that may suggest more serious conditions
• Consider simple cheap interventions, such as minor feed modifications or thickening agents, when possible and avoid acid suppressing drugs in isolated overt regurgitation
• Do not use upper gastrointestinal contrast radiology to diagnose or assess the severity of gastro-oesophageal reflux disease. This test is indicated for other reasons such as dysphagia or unexplained bile stained vomiting
Definitions used in the guideline
Gastro-oesophageal reflux: The passage of gastric contents into the oesophagus. It is a common physiological event that can happen at all ages from infancy to old age and is often asymptomatic. It is more common after feeds or meals. In many infants it is associated with a tendency to "overt regurgitation"-the visible regurgitation of feeds.
Gastro-oesophageal reflux disease: Gastro-oesophageal reflux that causes symptoms (for example, discomfort or pain) severe enough to merit medical treatment or that has associated complications (such as oesophagitis or pulmonary aspiration). In adults, the term is often used more narrowly, referring specifically to reflux oesophagitis.
Marked distress:
There is limited evidence, and no objective or widely accepted clinical definition, for what constitutes marked distress in infants and children who cannot adequately communicate their sensory emotions. In this guideline, marked distress refers to an outward demonstration of pain or unhappiness outside of that considered to be the normal range by an appropriately trained competent healthcare professional on the basis of a thorough assessment. This assessment should include a careful analysis of the description offered by the parents or carers of the individual child.
[ • Arrange an urgent specialist hospital assessment to take place on the same day for infants younger than 2 months with progressively worsening or forceful vomiting of feeds to assess them for possible hypertrophic pyloric stenosis.
[Based on the experience and opinion of the GDG.]
• For recommendations relating to the indications for endoscopy and oesophageal pH study or impedance monitoring, see the further information box.
• Investigate the possibility of a urinary tract infection in infants with regurgitation if there is: -Faltering growth -Late onset of regurgitation (after age 8 weeks)
-Frequent regurgitation and marked distress.
[Based on the experience and opinion of the GDG.]
Initial management of gastro-oesophageal reflux and GORD • For further recommendations on enteral tube feeding and surgery see the further information box.
Overcoming barriers
It can be difficult to persuade families that distressing and disabling symptoms (such as frequent and severe vomiting in thriving infants) will almost certainly improve with time but can be helped by relatively minor interventions, rather than referral for unnecessary tests or the use of drugs with no confirmed effect. This guideline offers clear direction as to when and how families can be appropriately reassured and provides links to downloadable information for parents. However, for different clinical presentations or evolving symptoms, especially potentially serious red flag presentations, the guideline recommends actions that are clearly necessary by way of investigation, treatment, and referral. 
Methods
This guidance was developed by the National Collaborating Centre for Women's and Children's Health in accordance with NICE guideline development methods (www.nice.org.uk/guidelinesmanual). The Guideline Development Group (GDG) comprised two paediatric gastroenterologists (including the chair); a paediatrician; a neonatologist; a consultant in paediatric neurodisability; a paediatric surgeon; two general practitioners; an advanced paediatric nurse practitioner; a paediatric dietitian; a health visitor; lay members with experience of caring for such infants, children, or young people; and experts in guideline methodology. There was also a pharmacist as an "invited expert." The GDG identified relevant clinical questions, collected and appraised clinical evidence, and where possible evaluated the cost effectiveness of proposed interventions. The draft guideline underwent a public consultation and a validation process in which stakeholder organisations were invited to comment; all comments were considered when producing the final version of the guideline.
NICE has produced four different versions of the guideline: a full version containing all the evidence, the process undertaken to develop the recommendations, and all the recommendations; a version containing a list of all the recommendations, known as the "NICE guideline"; a version for patients and the public (www.nice.org. uk/guidance/NG1/informationforpublic); and a web version of the care pathway (the "NICE pathway"). All these versions are available from the NICE website (www. nice.org.uk/guidance/NG1). Implementation tools will also be available from the NICE website. The guideline will be reviewed for update in two years' time as part of the NICE guideline development programme.
Future research
A prospective cohort study to evaluate the diagnostic accuracy of symptoms associated with GORD in infants, children, and young people with complex severe neurodisability to detect GORD (diagnosed as reflux oesophagitis identified by endoscopy and oesophageal pH monitoring).
A randomised controlled trial in formula fed infants with suspected GORD that compares the effects of an extensively hydrolysed formula feed versus a placebo milk substitute on clinical symptoms and the results of objective measurements (endoscopy and oesophageal pH monitoring).
A prospective evaluation of objective symptom profiles, oesophageal pH monitoring, and upper gastrointestinal endoscopy before and after fundoplication surgery in children with GORD.
Further recommendations
Gastrointestinal contrast study
• Do not offer an upper gastrointestinal contrast study to diagnose or assess the severity of GORD in infants, children, and young people. [Based on the experience and opinion of the GDG.]
• Perform an urgent (same day) upper gastrointestinal contrast study for infants with unexplained bile stained vomiting. Explain to the parents and carers that this is needed to rule out serious disorders such as intestinal obstruction caused by midgut volvulus. [Based on the experience and opinion of the GDG.]
• Consider an upper gastrointestinal contrast study for children and young people with a history of bile stained vomiting, particularly if it is persistent or recurrent. [Based on high, moderate, and low quality evidence from observational studies and on the experience and opinion of the GDG.]
• Consider performing an oesophageal pH study without impedance monitoring in infants, children, and young people if, using clinical judgment, this is thought necessary to ensure effective acid suppression. [Based on the experience and opinion of the GDG.] Enteral tube feeding for GORD
• Consider enteral tube feeding to promote weight gain in infants and children with overt regurgitation and faltering growth only if: -Other explanations for poor weight gain have been explored or -Recommended feeding and medical management of overt regurgitation is unsuccessful. • Before starting enteral tube feeding for infants and children with faltering growth associated with overt regurgitation, agree in advance: -A specific individualised nutrition plan -A strategy to reduce enteral tube feeding as soon as possible -An exit strategy, if appropriate, to stop enteral tube feeding as soon as possible.
• In infants and children receiving enteral tube feeding for faltering growth associated with overt regurgitation: -Provide oral stimulation, continuing oral feeding as tolerated -Follow the nutrition plan, ensuring that the intended target weight is achieved and that appropriate weight gain is sustained -Reduce and stop enteral tube feeding as soon as possible.
• Consider jejunal feeding for infants, children, and young people: -Who need enteral tube feeding but who cannot tolerate intragastric feeds because of regurgitation or -If reflux related pulmonary aspiration is a concern.
[Based on the experience and opinion of the GDG.] Investigations before surgery
• Offer an upper gastrointestinal endoscopy with oesophageal biopsies for infants, children, and young people before deciding whether to offer fundoplication for presumed GORD. [Based on the experience and opinion of the GDG.]
• Consider performing other investigations such as an oesophageal pH study (or combined oesophageal pH and impedance monitoring if available) and an upper gastrointestinal contrast study in infants, children, and young people before deciding whether to offer fundoplication. [Based on the experience and opinion of the GDG.] Table   Table 1| Infants and children with, or at high risk of, atopy *Specialist refers to a paediatrician with the skills, experience, and competency necessary to deal with the particular clinical concern that has been identified by the referring healthcare professional, usually a consultant general paediatrician. Depending on the clinical circumstances, specialist may also refer to a paediatric surgeon, paediatric gastroenterologist, or a doctor with the equivalent skills and competency.
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